LSE$AZN

AstraZeneca · Q1 2015 earnings

Q1 2015 earnings · · Investor relations

Headline financials

Total Revenue

£5.75B

No prior period
EPS (adj)

£1.08

No prior period

Revenue & EPS history

AstraZeneca · Revenue · Quarterly

£5.75B

Q1 2015
Beat estimate in 10 of 16 quarters(63%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports

Historical avg

+0.8%

Avg return

Earnings day

+1.8%

Avg return

5 days after

+181.0%

Avg return

30 days after

56%

23 / 41 earnings

Positive

+11.9%

Q4 2018

Best reaction

-10.8%

Q2 2017

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026+0.4%+0.1%+6432.5%
Q3 2025+2.9%+9.8%+11.1%
Q2 2025+6.8%+3.0%+11.4%
Q4 2024+1.5%+3.4%+4.2%
Q1 2024+5.6%-2.3%+8.7%
Q4 2023-6.4%-8.3%-0.1%
Q3 2023-0.6%+1.1%-0.4%
Q2 2023+5.2%+3.4%+0.2%
Q1 2023-0.6%+0.1%-1.5%
Q4 2022+7.0%+9.3%-0.3%
Q3 2022+2.8%+4.8%+13.9%
Q2 2022-1.6%-2.1%-0.6%
Q1 2022-1.2%-0.7%+0.3%
Q4 2021+1.5%+5.4%+5.4%
Q3 2021-5.0%-8.2%-14.1%
Q2 2021+0.8%+2.6%-4.1%
Q1 2021+4.5%+4.4%+10.5%
Q4 2020+3.4%+1.8%-3.1%
Q3 2020+0.9%+2.8%-2.4%
Q2 2020-1.5%-1.0%-1.7%
Q1 2020+2.6%+2.7%+7.1%
Q4 2019-0.4%-0.0%-14.3%
Q3 2019+6.7%+6.5%+7.3%
Q2 2019+7.8%+1.4%+14.0%
Q1 2019-2.3%+8.7%+10.5%
Q4 2018+11.9%+10.6%+16.2%
Q3 2018+4.5%+5.8%-2.6%
Q2 2018+2.1%+4.5%+2.3%
Q1 2018+1.0%+1.1%-0.1%
Q4 2017-3.9%+0.7%+4.9%
Q3 2017-1.3%-0.2%-1.8%
Q2 2017-10.8%-11.8%-13.8%
Q1 2017-1.1%+0.4%+10.7%
Q4 2016+0.6%+1.8%+7.8%
Q3 2016-3.4%-4.6%-6.2%
Q2 2016+8.2%+8.5%+4.8%
Q1 2016+0.0%
Q4 2015-7.3%
Q3 2015-0.1%
Q1 2015-3.3%
Q4 2014-4.7%
Q3 2014
Q2 2014
Q1 2014
Q4 2013

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro